Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04964518 |
| Recruiting Status | Unknown |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Ascentage Pharma Group Inc. |
| Last Updated on CT.gov | October 25, 2023 (Oct 25, 2023) |
As of March 2, 2026: Clinical trial NCT04964518 is currently unknown participants. This clinical trial study for acute myeloid leukemia is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Ascentage Pharma Group Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04964518 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04964518 was last updated Oct 25, 2023 (October 25, 2023). HelloStudys verifies this status automatically.